A new in vitro model using small intestinal epithelial cells to enhance infection of Cryptosporidium parvum

Journal of Microbiological Methods

Volumn 106, Issue , 2014, Pages 47-54

  Varughese, Eunice A ^a,b   Bennett Stamper, Christina L ^c   Wymer, Larry J ^b   Yadav, Jagjit S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cryptosporidium parvum; Excystation; FHs 74 Int; In vitro; Infection; Parasite

Indexed keywords

AGS CELL LINE; ARTICLE; CACO 2 CELL LINE; CELL LINE; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; FHS 74 INT CELL LINE; HCT 8 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFECTION SENSITIVITY; INTESTINE EPITHELIUM CELL; MDBK CELL LINE; MDCK CELL LINE; NONHUMAN; OOCYST; PRIORITY JOURNAL; SPOROZOITE; ANIMAL CELL; CELL TYPE; CRYPTOSPORIDIOSIS; DISEASE MODEL; EPITHELIUM CELL; INFECTION RATE; PARASITE VIRULENCE; SMALL INTESTINE; ENDOCYTOSIS; GROWTH, DEVELOPMENT AND AGING; PARASITOLOGY; PHYSIOLOGY;

CELL LINE; CRYPTOSPORIDIUM PARVUM; ENDOCYTOSIS; EPITHELIAL CELLS; HUMANS; INTESTINE, SMALL;

EID: 84906495023     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2014.07.017     Document Type: Article

References (48)

1. Arrowood M.J. In vitro cultivation of Cryptosporidium species. Clin. Microbiol. Rev. 2002, 15:390-400.
2. Attene-Ramos M.S., Nava G.M., Muellner M.G., Wagner E.D., Plewa M.J., Gaskins H.R. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ. Mol. Mutagen. 2010, 51:304-314.
3. Belosevic M., Guy R.A., Taghi-Kilani R., Neumann N.F., Gyurek L.L., Liyanage L.R., Millard P.J., Finch G.R. Nucleic acid stains as indicators of Cryptosporidium parvum oocyst viability. Int. J. Parasitol. 1997, 27:787-798.
4. Bojsen A., Buesa J., Montava R., Kvistgaard A.S., Kongsbak M.B., Petersen T.E., Heegaard C.W., Rasmussen J.T. Inhibitory activities of bovine macromolecular whey proteins on rotavirus infections in vitro and in vivo. J. Dairy Sci. 2007, 90:66-74.
5. Buraud M., Forget E., Favennec L., Bizet J., Gobert J.G., Deluol A.M. Sexual stage development of cryptosporidia in the Caco-2 cell line. Infect. Immun. 1991, 59:4610-4613.
6. Campbell A.T., Robertson L.J., Smith H.V., Girdwood R.W. Viability of Cryptosporidium parvum oocysts concentrated by calcium carbonate flocculation. J. Appl. Bacteriol. 1994, 76:638-639.
7. Carey C.M., Lee H., Trevors J.T. Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst. Water Res. 2004, 38:818-862.
8. Castellanos-Gonzalez A., Cabada M.M., Nichols J., Gomez G., White A.C. Human primary intestinal epithelial cells as an improved in vitro model for Cryptosporidium parvum infection. Infect. Immun. 2013, 81:1996-2001.
9. Enriquez F.J., Sterling C.R. Cryptosporidium infections in inbred strains of mice. J. Protozool. 1991, 38:100S-102S.
10. Feng H., Nie W., Sheoran A., Zhang Q., Tzipori S. Bile acids enhance invasiveness of Cryptosporidium spp. into cultured cells. Infect. Immun. 2006, 74:3342-3346.
11. Friis L.M., Pin C., Pearson B.M., Wells J.M. In vitro cell culture methods for investigating Campylobacter invasion mechanisms. J. Microbiol. Methods 2005, 61:145-160.
12. Gold D., Stein B., Tzipori S. The utilization of sodium taurocholate in excystation of Cryptosporidium parvum and infection of tissue culture. J. Parasitol. 2001, 87:997-1000.
13. Gut J., Nelson R.G. Cryptosporidium parvum: synchronized excystation in vitro and evaluation of sporozoite infectivity with a new lectin-based assay. J. Eukaryot. Microbiol. 1999, 46:56S-57S.
14. Gut J., Petersen C., Nelson R., Leech J. Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells. J. Protozool. 1991, 38:72S-73S.
15. Hashim A., Mulcahy G., Bourke B., Clyne M. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells. Infect. Immun. 2006, 74:99-107.
16. Hijjawi N. Cryptosporidium: new developments in cell culture. Exp. Parasitol. 2010, 124:54-60.
17. Jenkins M.B., Anguish L.J., Bowman D.D., Walker M.J., Ghiorse W.C. Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts. Appl. Environ. Microbiol. 1997, 63:3844-3850.
18. Karanis P., Aldeyarbi H.M. Evolution of Cryptosporidium in vitro culture. Int. J. Parasitol. 2011, 41:1231-1242.
19. King B.J., Keegan A.R., Robinson B.S., Monis P.T. Cryptosporidium cell culture infectivity assay design. Parasitology 2011, 1-11.
20. Kothavade R.J. Potential molecular tools for assessing the public health risk associated with waterborne Cryptosporidium oocysts. J. Med. Microbiol. 2012, 61:1039-1051.
21. Lacroix M. Persistent use of "false" cell lines. Int. J. Cancer 2008, 122:1-4.
22. Lalancette C., Di Giovanni G.D., Prevost M. Improved risk analysis by dual direct detection of total and infectious Cryptosporidium oocysts on cell culture in combination with immunofluorescence assay. Appl. Environ. Microbiol. 2010, 76:566-577.
23. Liu B., Yu Z., Chen C., Kling D.E., Newburg D.S. Human milk mucin 1 and mucin 4 inhibit Salmonella enterica serovar Typhimurium invasion of human intestinal epithelial cells in vitro. J. Nutr. 2012, 142:1504-1509.
24. Martin-Gomez S., Alvarez-Sanchez M., Rojo-Vazquez F. A newborn mouse Cryptosporidium parvum infection model: its application to the study of therapeutic and prophylactic measures for controlling cryptosporidiosis in ruminants. Parasitol. Res. 2006, 99:1-6.
25. McCullagh P., Nelder J. Generalized Linear Models 1989, Chapman and Hall/CRC, Boca Raton. Second edition.
26. Millau J.F., Mai S., Bastien N., Drouin R. p53 functions and cell lines: have we learned the lessons from the past?. Bioessays 2010, 32:392-400.
27. Miller T.A., Schaefer F.W. Characterization of a single dose methylprednisolone acetate immune suppression model using Cryptosporidium muris and Cryptosporidium parvum. Vet. Parasitol. 2006, 141:66-83.
28. Mirpuri J., Brazil J.C., Berardinelli A.J., Nasr T.R., Cooper K., Schnoor M., Lin P.W., Parkos C.A., Louis N.A. Commensal Escherichia coli reduces epithelial apoptosis through IFN-alphaA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine. J. Immunol. 2010, 184:7186-7195.
29. Najdrowski M., Joachim A., Daugschies A. An improved in vitro infection model for viability testing of Cryptosporidium parvum oocysts. Vet. Parasitol. 2007, 150:150-154.
30. Neumann N.F., Gyurek L.L., Gammie L., Finch G.R., Belosevic M. Comparison of animal infectivity and nucleic acid staining for assessment of Cryptosporidium parvum viability in water. Appl. Environ. Microbiol. 2000, 66:406-412.
31. Pollok R.C., Farthing M.J., Bajaj-Elliott M., Sanderson I.R., McDonald V. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 2001, 120:99-107.
32. Ramirez N.E., Ward L.A., Sreevatsan S. A review of the biology and epidemiology of cryptosporidiosis in humans and animals. Microbes Infect. 2004, 6:773-785.
33. Rochelle P.A., Marshall M.M., Mead J.R., Johnson A.M., Korich D.G., Rosen J.S., De Leon R. Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum. Appl. Environ. Microbiol. 2002, 68:3809-3817.
34. Rochelle P.A., Fallar D., Marshall M.M., Montelone B.A., Upton S.J., Woods K. Irreversible UV inactivation of Cryptosporidium spp. despite the presence of UV repair genes. J. Eukaryot. Microbiol. 2004, 51:553-562.
35. Schets F.M., Engels G.B., During M., de Roda Husman A.M. Detection of infectious Cryptosporidium oocysts by cell culture immunofluorescence assay: applicability to environmental samples. Appl. Environ. Microbiol. 2005, 71:6793-6798.
36. Slifko T.R., Friedman D., Rose J.B., Jakubowski W. An in vitro method for detecting infectious Cryptosporidium oocysts with cell culture. Appl. Environ. Microbiol. 1997, 63:3669-3675.
37. Smith H.V., Nichols R.A. Cryptosporidium: detection in water and food. Exp. Parasitol. 2010, 124:61-79.
38. Tzipori S., Ward H. Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect. 2002, 4:1047-1058.
39. Upton S.J., Tilley M., Brillhart D.B. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol. Lett. 1994, 118:233-236.
40. Upton S.J., Tilley M., Brillhart D.B. Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells. J. Clin. Microbiol. 1995, 33:371-375.
41. Valigurova A., Jirku M., Koudela B., Gelnar M., Modry D., Slapeta J. Cryptosporidia: epicellular parasites embraced by the host cell membrane. Int. J. Parasitol. 2008, 38:913-922.
42. Widmer G., Klein P., Bonilla R. Adaptation of Cryptosporidium oocysts to different excystation conditions. Parasitology 2007, 134:1583-1588.
43. Woods K.M., Upton S.J. In vitro development of Cryptosporidium parvum in serum-free media. Lett. Appl. Microbiol. 2007, 44:520-523.
44. Wu L., Chen S.X., Jiang X.G., Shen Y.J., Lu Z.X., Tu G.H., Fu X.L., Cao J.P. Effect of select medium supplements on in vitro development of Cryptosporidium andersoni in HCT-8 cells. Parasitol. Res. 2009, 105:1419-1424.
45. Xiao L. Molecular epidemiology of cryptosporidiosis: an update. Exp. Parasitol. 2009, 124:80-89.
46. Xiao L., Fayer R., Ryan U., Upton S.J. Cryptosporidium taxonomy: recent advances and implications for public health. Clin. Microbiol. Rev. 2004, 17:72-97.
47. Yang S., Healey M.C., Du C., Zhang J. Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. Infect. Immun. 1996, 64:349-354.
48. Yu J.R., Choi S.D., Kim Y.W. In vitro infection of Cryptosporidium parvum to four different cell lines. Korean J. Parasitol. 2000, 38:59-64.